Prevention of deep vein thrombosis by low-molecular-weight heparin and dihydroergotamine in patients undergoing total hip replacement
- 1 July 1991
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 63 (1) , 133-143
- https://doi.org/10.1016/0049-3848(91)90276-3
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986
- The current status of low‐dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolismWorld Journal of Surgery, 1978
- Prevention of venous thrombosis with small, subcutaneous doses of heparinPublished by American Medical Association (AMA) ,1976
- EFFICACY OF LOW-DOSE HEPARIN IN PREVENTION OF EXTENSIVE DEEP-VEIN THROMBOSIS IN PATIENTS UNDERGOING TOTAL-HIP REPLACEMENTThe Lancet, 1976
- FAILURE OF LOW-DOSE HEPARIN TO PREVENT DEEP-VEIN THROMBOSIS AFTER HIP-REPLACEMENT ARTHROPLASTYThe Lancet, 1974
- EFFICACY OF LOW DOSES OF HEPARIN IN PREVENTION OF DEEP-VEIN THROMBOSIS AFTER MAJOR SURGERYThe Lancet, 1972